Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microbial Asymmetric Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110004081A details a novel biocatalytic route for gamma-lactam. This method ensures high optical purity and offers significant supply chain cost reduction advantages.
Patent CN102161978B reveals a green Rhodococcus strain for Cilastatin intermediates. Achieve high optical purity with reduced environmental impact and lower manufacturing costs.